Boris Knyazer1, Tova Lifshitz, Mira Marcus, Asaff Kratz, Alex Zlotnik, Jaime Levy. Show Affiliations » 1. Department of Ophthalmology, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel. knyazer@bgu.ac.il
Abstract
Entities: Chemical Disease Species
Mesh: See more » AdultAntiviral Agents/administration & dosageAntiviral Agents/adverse effectsAntiviral Agents/therapeutic useDrug Therapy, CombinationGlucocorticoids/administration & dosageHepatitis C/drug therapyHumansInterferon alpha-2Interferon-alpha/administration & dosageInterferon-alpha/adverse effectsInterferon-alpha/therapeutic useMaleMethylprednisolone/administration & dosageOptic Neuropathy, Ischemic/chemically inducedOptic Neuropathy, Ischemic/drug therapyPolyethylene Glycols/administration & dosagePolyethylene Glycols/adverse effectsPolyethylene Glycols/therapeutic usePrednisone/administration & dosageRecombinant ProteinsRibavirin/administration & dosageRibavirin/therapeutic useVisual Acuity
Substances: See more » Antiviral AgentsGlucocorticoidsInterferon alpha-2Interferon-alphaRecombinant ProteinsPolyethylene GlycolsRibavirinpeginterferon alfa-2aPrednisoneMethylprednisolone
Year: 2011 PMID: 21598818
Source DB: PubMed Journal: Isr Med Assoc J Impact factor: 0.892